Literature DB >> 21293291

Hydatidiform moles: ancillary techniques to refine diagnosis.

Brigitte M Ronnett1, Cheryl DeScipio, Kathleen M Murphy.   

Abstract

Distinction of hydatidiform moles from nonmolar specimens and subclassification of hydatidiform moles as complete hydatidiform mole (CHM), partial hydatidiform mole (PHM), or early CHM are important for both clinical practice and investigational studies. The risk of persistent gestational trophoblastic disease and hence, clinical management, differs for CHMs, PHMs, and nonmolar specimens. However, diagnosis based solely on morphology suffers from poor interobserver reproducibility and remains problematic even for experienced gynecologic pathologists. The unique genetic features of CHMs (androgenetic diploidy), PHMs (diandric triploidy), and nonmolar specimens (biparental diploidy) allow for certain molecular techniques, including immunohistochemical analysis of p57 expression (a paternally imprinted maternally expressed gene) and molecular genotyping, to refine the diagnosis of hydatidiform moles. Although p57 immunostaining alone can identify CHMs, which lack p57 expression because of the lack of maternal DNA, this analysis cannot distinguish PHMs from nonmolar specimens as both express p57 because of the presence of maternal DNA. Short tandem repeat genotyping, which can determine the parental source of polymorphic alleles, can distinguish among all of these entities by discerning androgenetic diploidy, diandric triploidy, and biparental diploidy to rigorously diagnose CHMs, PHMs, and nonmolar specimens, respectively. An algorithmic approach using these techniques to refine morphologic diagnosis has been developed for routine practice. This review discusses current issues in the diagnosis of hydatidiform moles, including the limitations of morphologic diagnosis, the need for refined diagnosis to assure accurate ascertainment of risk of persistent gestational trophoblastic disease associated with the different subtypes of hydatidiform moles, the use of ancillary immunohistochemical and molecular techniques for providing such refined diagnosis, and problems that can be encountered with these techniques.

Entities:  

Mesh:

Year:  2011        PMID: 21293291     DOI: 10.1097/PGP.0b013e3181f4de77

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  15 in total

1.  STR DNA genotyping of hydatidiform moles in South China.

Authors:  Xing-Zheng Zheng; Pei Hui; Bin Chang; Zhi-Bin Gao; Yan Li; Bing-Quan Wu; Bo Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

2.  Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis.

Authors:  Russell Vang; Mamta Gupta; Lee-Shu-Fune Wu; Anna V Yemelyanova; Robert J Kurman; Kathleen M Murphy; Cheryl Descipio; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2012-03       Impact factor: 6.394

3.  Identification of a hydatidiform mole in twin pregnancy following assisted reproduction.

Authors:  Yan Liu; Xingzheng Zheng; Yuxiang Wang; Yan Li; Congrong Liu
Journal:  J Assist Reprod Genet       Date:  2019-12-12       Impact factor: 3.412

4.  Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis for both recently trained and experienced gynecologic pathologists.

Authors:  Mamta Gupta; Russell Vang; Anna V Yemelyanova; Robert J Kurman; Fanghong Rose Li; Emily C Maambo; Kathleen M Murphy; Cheryl DeScipio; Carol B Thompson; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2012-12       Impact factor: 6.394

5.  Partial hydatidiform mole pregnancy ended in full-term delivery of a normal infant: a case presentation.

Authors:  Qing-Hua Qu; Yi Lin; Xue Feng; Li-Juan Hao
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

6.  Gestational Trophoblastic Disease - Clinicopathological Study at Tertiary Care Hospital.

Authors:  Sunil Vitthalrao Jagtap; Vidhya Aher; Suchi Gadhiya; Swati Sunil Jagtap
Journal:  J Clin Diagn Res       Date:  2017-08-01

Review 7.  Genotyping diagnosis of gestational trophoblastic disease: frontiers in precision medicine.

Authors:  Natalia Buza; Pei Hui
Journal:  Mod Pathol       Date:  2021-06-04       Impact factor: 7.842

8.  Ki-67 expression in hydatidiform moles and hydropic abortions.

Authors:  Alireza Khooei; Fatemeh Atabaki Pasdar; Alireza Fazel; Mahmoud Mahmoudi; Mohammad Reza Nikravesh; Mohammad Khaje Delui; Bagher Pourheydar
Journal:  Iran Red Crescent Med J       Date:  2013-07-05       Impact factor: 0.611

9.  Differentiating complete hydatidiform mole and coexistent fetus and placental mesenchymal dysplasia: A series of 9 cases and review of the literature.

Authors:  Leah McNally; Joseph T Rabban; Liina Poder; Shilpa Chetty; Stefanie Ueda; Lee-May Chen
Journal:  Gynecol Oncol Rep       Date:  2021-06-10

10.  Loss of p57 Expression in Conceptions Other Than Complete Hydatidiform Mole: A Case Series With Emphasis on the Etiology, Genetics, and Clinical Significance.

Authors:  Deyin Xing; Karin Miller; Katie Beierl; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2022-01-01       Impact factor: 6.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.